Suppr超能文献

胃动素1在胃癌中的作用及诊断潜力

The role and diagnostic potential of gastrokine 1 in gastric cancer.

作者信息

Koper-Lenkiewicz Olga M, Kamińska Joanna, Gawrońska Beata, Matowicka-Karna Joanna

机构信息

Department of Clinical Laboratory Diagnostics, Medical University of Bialystok, Białystok, Poland,

出版信息

Cancer Manag Res. 2019 Mar 1;11:1921-1931. doi: 10.2147/CMAR.S194949. eCollection 2019.

Abstract

INTRODUCTION

Gene for () was identified as one of the most significant in gastric cancer and indicated as a potential therapeutic target.

AIM

The aim was a review of literature reports concerning the role and diagnostic potential of GKN1 in gastric cancer.

MATERIALS AND METHODS

PubMED database was searched for sources using the following keywords: gastrokine 1/GKN1/AMP-18 and gastric cancer, , aspirin, nonsteroidal anti-inflammatory drugs. Preference was given to the sources which were published within the past 10 years.

CONCLUSION

GKN1 is a stomach-specific protein, and its role consists of maintaining mucosal integrity as well as the replenishment of the surface lumen epithelial cells layer. The evaluation of GKN1 expression seems to be a useful indicator of the presence of neoplastic or inflammatory lesions in the gastric mucosa. GKN1 expression is decreased in gastric tumor tissues and derived cell lines and its upregulation in cell lines of gastric cancer induces cells apoptosis. The mechanism by which GKN1 is inactivated in gastric cancer cells is still not fully understood. The future diagnostic capabilities of gastric cancer concern the assessment of serum GKN1 concentration by means of ELISA method. Serum GKN1 concentration is not related to patients' sex. Moreover, the measurement of GKN1 concentration is possible only after the incubation of samples at 70°C for 10 minutes. Nevertheless, the aspect of quantitative serum GKN1 evaluation is new in the context of available literature and requires further studies.

摘要

引言

()基因被确定为胃癌中最重要的基因之一,并被视为潜在的治疗靶点。

目的

目的是综述有关GKN1在胃癌中的作用和诊断潜力的文献报道。

材料与方法

在PubMed数据库中使用以下关键词搜索资料来源:胃动素1/GKN1/AMP-18与胃癌、、阿司匹林、非甾体抗炎药。优先选择过去10年内发表的资料来源。

结论

GKN1是一种胃特异性蛋白,其作用包括维持黏膜完整性以及补充表面腔上皮细胞层。评估GKN1表达似乎是胃黏膜中肿瘤性或炎性病变存在的有用指标。GKN1在胃肿瘤组织和衍生细胞系中的表达降低,其在胃癌细胞系中的上调诱导细胞凋亡。GKN1在胃癌细胞中失活的机制仍未完全了解。未来胃癌的诊断能力涉及通过ELISA方法评估血清GKN1浓度。血清GKN1浓度与患者性别无关。此外,只有在将样品在70°C孵育10分钟后才能测量GKN1浓度。然而,在现有文献的背景下,血清GKN1定量评估方面是新的,需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d42/6402446/02bda876ee38/cmar-11-1921Fig1.jpg

相似文献

1
The role and diagnostic potential of gastrokine 1 in gastric cancer.
Cancer Manag Res. 2019 Mar 1;11:1921-1931. doi: 10.2147/CMAR.S194949. eCollection 2019.
2
Overexpression of gastrokine 1 in gastric cancer cells induces Fas-mediated apoptosis.
J Cell Physiol. 2011 Oct;226(10):2571-8. doi: 10.1002/jcp.22601.
3
Helicobacter pylori inhibits GKN1 expression via the CagA/p-ERK/AUF1 pathway.
Helicobacter. 2020 Feb;25(1):e12665. doi: 10.1111/hel.12665. Epub 2019 Oct 27.
4
The role of gastrokine 1 in gastric cancer.
J Gastric Cancer. 2014 Sep;14(3):147-55. doi: 10.5230/jgc.2014.14.3.147. Epub 2014 Sep 30.
5
Ectopic expression of gastrokine 1 in gastric cancer cells up-regulates tight and adherens junction proteins network.
Pathol Res Pract. 2015 Aug;211(8):577-83. doi: 10.1016/j.prp.2015.04.008. Epub 2015 Apr 28.
6
Epigenetic alterations of gastrokine 1 gene expression in gastric cancer.
Oncotarget. 2017 Mar 7;8(10):16899-16911. doi: 10.18632/oncotarget.14817.
8
Gastrokine 1 protein is a potential theragnostic target for gastric cancer.
Gastric Cancer. 2018 Nov;21(6):956-967. doi: 10.1007/s10120-018-0828-8. Epub 2018 Apr 27.
9
GKN1-miR-185-DNMT1 axis suppresses gastric carcinogenesis through regulation of epigenetic alteration and cell cycle.
Clin Cancer Res. 2013 Sep 1;19(17):4599-610. doi: 10.1158/1078-0432.CCR-12-3675. Epub 2013 Jul 11.
10
GKN2 contributes to the homeostasis of gastric mucosa by inhibiting GKN1 activity.
J Cell Physiol. 2014 Jun;229(6):762-71. doi: 10.1002/jcp.24496.

引用本文的文献

2
Protein Biomarkers of Gastric Preneoplasia and Cancer Lesions in Blood: A Comprehensive Review.
Cancers (Basel). 2024 Aug 29;16(17):3019. doi: 10.3390/cancers16173019.
3
IL-33 Accelerates Chronic Atrophic Gastritis through AMPK-ULK1 Axis Mediated Autolysosomal Degradation of GKN1.
Int J Biol Sci. 2024 Apr 8;20(6):2323-2338. doi: 10.7150/ijbs.93573. eCollection 2024.
4
Combinatorial Herbal Extracts Alleviate Alcohol-Induced Hepatic Disorders.
Plant Foods Hum Nutr. 2023 Jun;78(2):432-438. doi: 10.1007/s11130-023-01057-7. Epub 2023 Jun 16.
5
Helicobacter pylori Thioredoxin1 May Play a Highly Pathogenic Role via the IL6/STAT3 Pathway.
Gastroenterol Res Pract. 2022 Aug 1;2022:3175935. doi: 10.1155/2022/3175935. eCollection 2022.
6
Research progress on exosomal proteins as diagnostic markers of gastric cancer (review article).
Clin Exp Med. 2023 Jun;23(2):203-218. doi: 10.1007/s10238-022-00793-5. Epub 2022 Jan 22.
8
Coordinate expression loss of and in gastric cancer via impairment of a glucocorticoid-responsive enhancer.
Am J Physiol Gastrointest Liver Physiol. 2020 Aug 1;319(2):G175-G188. doi: 10.1152/ajpgi.00019.2020. Epub 2020 Jun 15.

本文引用的文献

2
Gastrokine 1 protein is a potential theragnostic target for gastric cancer.
Gastric Cancer. 2018 Nov;21(6):956-967. doi: 10.1007/s10120-018-0828-8. Epub 2018 Apr 27.
3
Clinical value of combined tests for tumor markers for gastric cancer.
J Biol Regul Homeost Agents. 2018 Mar-Apr;32(2):263-268.
6
Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
BMC Cancer. 2017 Nov 9;17(1):737. doi: 10.1186/s12885-017-3738-y.
9
Epigenetic alterations of gastrokine 1 gene expression in gastric cancer.
Oncotarget. 2017 Mar 7;8(10):16899-16911. doi: 10.18632/oncotarget.14817.
10
Gastrokine 1 mRNA in human sera is not informative biomarker for gastric cancer.
J Negat Results Biomed. 2016 Jul 25;15(1):14. doi: 10.1186/s12952-016-0057-9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验